UPDATED Mar 30, 2024
Stocks with a market cap under US$50M.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
EZ1 | US$0.047 | -17.5% | n/a | US$7.0m | n/a | PE71.6x | n/a | n/a | Pharmaceuticals & Biotech | ||
IO7 | €0.012 | 0% | -92.5% | €6.3m | n/a | PB2.1x | S-10.6% | n/a | Energy | ||
DZX | US$0.0085 | -19.0% | -37.0% | US$6.9m | n/a | PB0.2x | n/a | n/a | Materials | ||
5JN | CA$0.23 | -7.3% | -30.7% | CA$9.4m | n/a | PE19.9x | n/a | n/a | Capital Goods | ||
U01 | CA$0.015 | 14.8% | 106.7% | CA$9.4m | n/a | PB2.5x | E157.0% | n/a | Pharmaceuticals & Biotech | ||
C1Y | UK£0.073 | -8.7% | -45.6% | UK£5.5m | n/a | PB0.8x | E111.7% | 0% | Materials | ||
CE0 | HK$0.047 | 0% | -83.9% | HK$53.3m | n/a | PB0.5x | n/a | 0% | Retail | ||
4CP | €1.15 | -8.8% | -62.5% | €6.2m | n/a | PB2.4x | n/a | n/a | Capital Goods | ||
5JA1 | kr0.069 | -8.9% | 166.9% | kr71.9m | n/a | PS1.4x | S34.0% | n/a | Pharmaceuticals & Biotech | ||
84SA | CA$0.026 | 36.8% | 33.3% | CA$9.1m | n/a | PB1.8x | n/a | n/a | Pharmaceuticals & Biotech | ||
DQ6 | UK£0.0038 | 0% | -98.5% | UK£5.2m | UK£1.15 | PE-0.02x | n/a | n/a | Media | ||
AVI | AU$0.0015 | 0% | -87.5% | AU$10.3m | n/a | PE172.4x | n/a | n/a | Materials | ||
GV2A | UK£0.002 | 0% | -60.0% | UK£5.3m | n/a | PB2.6x | E25.7% | n/a | Software | ||
EZ1 | US$0.12 | 0% | -39.6% | US$6.7m | n/a | PS256.9x | n/a | n/a | Pharmaceuticals & Biotech | ||
NUQA | €1.40 | -0.7% | -23.1% | €6.2m | n/a | PS6.7x | n/a | 0% | Diversified Financials | ||
NUQA | €1.30 | -7.1% | n/a | €6.2m | n/a | PS6.7x | n/a | 0% | Diversified Financials | ||
A62 | €0.22 | 9.9% | -78.2% | €6.2m | n/a | PB0.2x | S8.6% | n/a | Capital Goods | ||
A62 | €0.24 | 0% | -74.1% | €6.2m | n/a | PB0.2x | S8.6% | n/a | Capital Goods | ||
MNS | €0.58 | -0.7% | -80.1% | €6.1m | €1.11 | PB0.5x | E110.0% | n/a | Tech | ||
49Y0 | US$0.14 | -2.1% | -86.1% | US$6.5m | US$15.28 | PB4.1x | E7.4% | n/a | Pharmaceuticals & Biotech | ||
49Y0 | US$0.15 | 0% | -85.9% | US$6.5m | US$16.72 | PB4.1x | E7.4% | n/a | Pharmaceuticals & Biotech | ||
EYE0 | UK£0.025 | 32.4% | -65.2% | UK£5.4m | n/a | PS1.2x | S30.2% | n/a | Software | ||
8A3 | UK£0.086 | 0% | 16.9% | UK£4.9m | n/a | PB0.5x | n/a | 0% | Automobiles | ||
7UX | kr0.023 | 0.9% | -66.8% | kr65.2m | n/a | PS11x | E56.0% | n/a | Pharmaceuticals & Biotech |